SOPH position history
The shares of Sophia Genetics (SOPH) that AKRE CAPITAL MANAGEMENT LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2024 Q1: 287,699 shares, $1.4M, New
- 2024 Q2: 1,920,432 shares, $8.8M, 0.08% of portfolio, Add +567.5%
- 2024 Q3: 2,237,504 shares, $8.2M, 0.07% of portfolio, Add +16.5%
- 2024 Q4: 2,237,504 shares, $6.9M, 0.06% of portfolio
- 2025 Q1: 2,237,504 shares, $7.4M, 0.07% of portfolio
- 2025 Q2: 3,719,140 shares, $12M, 0.11% of portfolio, Add +66.2%
- 2025 Q3: 3,719,140 shares, $18M, 0.18% of portfolio
- 2025 Q4: 3,719,140 shares, $17M, 0.19% of portfolio
- 2026 Q1: 3,719,140 shares, $18M, 0.30% of portfolio
- 2026 Q2: 3,719,140 shares, $21M, 0.42% of portfolio
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|